[go: up one dir, main page]

CN108484691A - A kind of chemical synthesis process of ribavirin condensation compound - Google Patents

A kind of chemical synthesis process of ribavirin condensation compound Download PDF

Info

Publication number
CN108484691A
CN108484691A CN201810687926.0A CN201810687926A CN108484691A CN 108484691 A CN108484691 A CN 108484691A CN 201810687926 A CN201810687926 A CN 201810687926A CN 108484691 A CN108484691 A CN 108484691A
Authority
CN
China
Prior art keywords
ribavirin
chemical synthesis
synthesis process
condensation compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810687926.0A
Other languages
Chinese (zh)
Inventor
宋伟新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mudanjiang Normal University
Original Assignee
Mudanjiang Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mudanjiang Normal University filed Critical Mudanjiang Normal University
Priority to CN201810687926.0A priority Critical patent/CN108484691A/en
Publication of CN108484691A publication Critical patent/CN108484691A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明公开了化学合成技术领域的一种利巴韦林缩合物的化学合成方法,该方法的具体步骤如下:S1:将1‑三甲基硅烷基‑1H‑1,2,4‑三唑‑3‑甲酰胺、六甲基二硅胺和硫酸铵添加至500ml的三颈瓶中;S2:减压蒸干,得到黄色油状物;S3:采用薄板层析色谱检测反应完全后,将反应液倒入碳酸氢钠的冰水中;S4:将步骤S3制得的产物溶于甲醇的氨饱和溶液中;S5:随后添加乙醇,充分搅拌后过滤;S6:合并后的滤饼在加热条件下溶于乙醇中,经过脱色剂脱色后,过滤冷却结晶,制得白色晶体粉末,本发明改进后的工艺原料易得,反应条件温和,各中间体均无需分离纯化,操作简便,总收率能够达到65%以上,制得的利巴韦林的纯度为99%以上。The invention discloses a chemical synthesis method of a ribavirin condensate in the technical field of chemical synthesis. The specific steps of the method are as follows: S1: 1-trimethylsilyl-1H-1,2,4-triazole ‑3‑formamide, hexamethyldisilamine and ammonium sulfate were added to a 500ml three-necked flask; S2: evaporated to dryness under reduced pressure to obtain a yellow oil; S3: after the reaction was detected by thin-plate chromatography, the reaction Pour the solution into ice water of sodium bicarbonate; S4: dissolve the product obtained in step S3 in a saturated ammonia solution of methanol; S5: then add ethanol, stir and filter; S6: combine the filter cake under heating conditions Soluble in ethanol, after being decolorized by a decolorizing agent, filtered and cooled to crystallize to obtain a white crystal powder, the improved process raw materials of the present invention are easy to obtain, the reaction conditions are mild, each intermediate does not need to be separated and purified, the operation is simple, and the total yield can reach Reaching more than 65%, the purity of the prepared ribavirin is more than 99%.

Description

一种利巴韦林缩合物的化学合成方法A kind of chemical synthesis method of ribavirin condensate

技术领域technical field

本发明公开了一种利巴韦林缩合物的化学合成方法,具体为化学合成技术领域。The invention discloses a chemical synthesis method of a ribavirin condensate, and specifically belongs to the technical field of chemical synthesis.

背景技术Background technique

病毒唑又名利巴韦林、三氮唑核苷、尼斯可等,是广谱强效的抗病毒药物,利巴韦林是一种抗病毒药,属合成核苷类药,对许多DNA和RNA病毒有抑制作用,其机理尚不清楚。目前广泛应用于病毒性疾病的防治。常用剂型有注射剂、片剂、口服液、气雾剂等。但是现有的利巴韦林合成方法在缩合时高温易使原料分解,收率较低;氨解时需高压反应长达几十小时;制备原料时需经过重氨化反应,易爆炸,制备过程不易操作。为此,我们提出了一种利巴韦林缩合物的化学合成方法投入使用,以解决上述问题。Ribavirin, also known as Ribavirin, Ribavirin, Niscor, etc., is a broad-spectrum and potent antiviral drug. Ribavirin is an antiviral drug that belongs to synthetic nucleoside drugs. and RNA viruses have inhibitory effect, the mechanism is not clear. It is widely used in the prevention and treatment of viral diseases. Common dosage forms include injections, tablets, oral liquids, aerosols, etc. However, in the existing ribavirin synthesis method, the high temperature during condensation is easy to decompose the raw material, and the yield is low; the high pressure reaction is required for tens of hours during ammonolysis; The process is not easy to operate. For this reason, we put forward a kind of chemical synthesis method of ribavirin condensate and put it into use, to solve the above-mentioned problems.

发明内容Contents of the invention

本发明的目的在于提供一种利巴韦林缩合物的化学合成方法,以解决上述背景技术中提出的问题。The object of the present invention is to provide a chemical synthesis method of ribavirin condensate, to solve the problems raised in the above-mentioned background technology.

为实现上述目的,本发明提供如下技术方案:一种利巴韦林缩合物的化学合成方法,该方法的具体步骤如下:In order to achieve the above object, the present invention provides the following technical scheme: a chemical synthesis method of ribavirin condensate, the specific steps of the method are as follows:

S1:将1-三甲基硅烷基-1H-1,2,4-三唑-3-甲酰胺、六甲基二硅胺和硫酸铵添加至500ml的三颈瓶中,加热回流反应至澄清,冷却至室温;S1: Add 1-trimethylsilyl-1H-1,2,4-triazole-3-carboxamide, hexamethyldisilazide and ammonium sulfate to a 500ml three-necked bottle, heat to reflux until clarification , cooled to room temperature;

S2:减压蒸干,得到黄色油状物,并将其溶于200~300ml的二氯甲烷中,添加四乙酰核糖,随后滴加氯化锡;S2: Evaporate to dryness under reduced pressure to obtain a yellow oil, and dissolve it in 200-300ml of dichloromethane, add tetraacetyl ribose, and then add tin chloride dropwise;

S3:采用薄板层析色谱检测反应完全后,将反应液倒入碳酸氢钠的冰水中,剧烈搅拌后静置分层,有机相用饱和碳酸氢钠水溶液洗涤,无水硫酸钠干燥,过滤,滤液减压蒸去溶剂;S3: After the completion of the reaction was detected by thin-plate chromatography, the reaction solution was poured into ice water with sodium bicarbonate, stirred vigorously and allowed to stand for stratification, the organic phase was washed with saturated aqueous sodium bicarbonate solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was distilled off the solvent under reduced pressure;

S4:将步骤S3制得的产物溶于甲醇的氨饱和溶液中,在室温下搅拌5~7h,析出白色沉淀,过滤,滤饼用甲醇洗涤后减压干燥;S4: Dissolving the product obtained in step S3 in a methanol-saturated ammonia solution, stirring at room temperature for 5-7 hours, a white precipitate precipitates, filtering, washing the filter cake with methanol, and drying under reduced pressure;

S5:随后添加乙醇,充分搅拌后过滤,滤饼用甲醇洗涤后,减压干燥并合并滤饼;S5: Add ethanol subsequently, filter after fully stirring, wash the filter cake with methanol, dry under reduced pressure and combine the filter cake;

S6:合并后的滤饼在加热条件下溶于乙醇中,经过脱色剂脱色后,过滤冷却结晶,制得白色晶体粉末。S6: The combined filter cakes are dissolved in ethanol under heating conditions, decolorized by a decolorizing agent, filtered and cooled to crystallize to obtain a white crystal powder.

优选的,所述步骤S1中,1-三甲基硅烷基-1H-1,2,4-三唑-3-甲酰胺的添加量为11~12g,六甲基二硅胺的添加量为200~300ml,硫酸铵的添加量为0.5~1g。Preferably, in the step S1, the added amount of 1-trimethylsilyl-1H-1,2,4-triazole-3-carboxamide is 11-12 g, and the added amount of hexamethyldisilamine is 200-300ml, the amount of ammonium sulfate added is 0.5-1g.

优选的,所述步骤S1中,加热的温度为95~100℃,加热时间为5~7h。Preferably, in the step S1, the heating temperature is 95-100° C., and the heating time is 5-7 hours.

优选的,所述步骤S2中,四乙酰核糖的添加量为30~40g,氯化锡的滴加量为5~7ml。Preferably, in the step S2, the amount of tetraacetyl ribose added is 30-40 g, and the amount of tin chloride added dropwise is 5-7 ml.

优选的,所述步骤S2中,在添加四乙酰核糖时,在冰浴中进行,且冰浴的温度控制在0~5℃。Preferably, in the step S2, when adding tetraacetyl ribose, it is carried out in an ice bath, and the temperature of the ice bath is controlled at 0-5°C.

优选的,所述步骤S3中,碳酸氢钠水溶液为100~120ml,洗涤3~5次。Preferably, in the step S3, the sodium bicarbonate aqueous solution is 100-120 ml and washed 3-5 times.

优选的,所述步骤S6中,加热的温度为40~60℃,并溶于95%、150~180ml的乙醇溶液中。Preferably, in the step S6, the heating temperature is 40-60°C, and the mixture is dissolved in 95%, 150-180ml ethanol solution.

优选的,所述步骤S6中,脱色剂为活性炭、白土或吸附树脂中的一种。Preferably, in the step S6, the decolorizing agent is one of activated carbon, clay or adsorption resin.

与现有技术相比,本发明的有益效果是:本发明改进后的工艺原料易得,反应条件温和,各中间体均无需分离纯化,操作简便,总收率能够达到65%以上,制得的利巴韦林的纯度为99%以上。Compared with the prior art, the beneficial effects of the present invention are: the improved process raw materials of the present invention are easy to obtain, the reaction conditions are mild, each intermediate does not need to be separated and purified, the operation is simple, the total yield can reach more than 65%, and the obtained The purity of ribavirin is above 99%.

具体实施方式Detailed ways

下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some of the embodiments of the present invention, but not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

实施例一Embodiment one

一种利巴韦林缩合物的化学合成方法,该方法的具体步骤如下:A kind of chemical synthesis method of ribavirin condensate, the concrete steps of this method are as follows:

S1:将1-三甲基硅烷基-1H-1,2,4-三唑-3-甲酰胺11g、六甲基二硅胺200ml和硫酸铵0.5g添加至500ml的三颈瓶中,加热回流反应至澄清,加热的温度为95℃,加热时间为5h,冷却至室温;S1: Add 11g of 1-trimethylsilyl-1H-1,2,4-triazole-3-carboxamide, 200ml of hexamethyldisilamine and 0.5g of ammonium sulfate to a 500ml three-necked bottle, and heat Reflux reaction until clarification, the heating temperature is 95°C, the heating time is 5h, and cooled to room temperature;

S2:减压蒸干,得到黄色油状物,并将其溶于200ml的二氯甲烷中,在冰浴中添加四乙酰核糖30g,且冰浴的温度控制在0℃,随后滴加氯化锡5ml;S2: Evaporate to dryness under reduced pressure to obtain a yellow oil, and dissolve it in 200ml of dichloromethane, add 30g of tetraacetyl ribose in an ice bath, and control the temperature of the ice bath at 0°C, then add tin chloride dropwise 5ml;

S3:采用薄板层析色谱检测反应完全后,将反应液倒入碳酸氢钠的冰水中,剧烈搅拌后静置分层,有机相用饱和碳酸氢钠水溶液100ml,洗涤3次,无水硫酸钠干燥,过滤,滤液减压蒸去溶剂;S3: After the completion of the reaction is detected by thin-plate chromatography, the reaction solution is poured into ice water of sodium bicarbonate, stirred vigorously and left to stand for stratification, and the organic phase is washed 3 times with 100 ml of saturated aqueous sodium bicarbonate solution, and anhydrous sodium sulfate Dry, filter, and evaporate the filtrate to remove the solvent under reduced pressure;

S4:将步骤S3制得的产物溶于甲醇的氨饱和溶液中,在室温下搅拌5h,析出白色沉淀,过滤,滤饼用甲醇洗涤后减压干燥;S4: dissolving the product obtained in step S3 in a saturated ammonia solution of methanol, stirring at room temperature for 5 hours, a white precipitate precipitated, filtered, and the filter cake was washed with methanol and dried under reduced pressure;

S5:随后添加乙醇,充分搅拌后过滤,滤饼用甲醇洗涤后,减压干燥并合并滤饼;S5: Add ethanol subsequently, filter after fully stirring, wash the filter cake with methanol, dry under reduced pressure and combine the filter cake;

S6:合并后的滤饼在加热条件下溶于95%、150ml的乙醇中,加热的温度为40℃,经过脱色剂脱色后,过滤冷却结晶,制得白色晶体粉末。S6: The combined filter cake is dissolved in 95%, 150ml of ethanol under heating conditions, the heating temperature is 40°C, after being decolorized by a decolorizing agent, it is filtered and cooled to crystallize to obtain a white crystal powder.

实施例二Embodiment two

一种利巴韦林缩合物的化学合成方法,该方法的具体步骤如下:A kind of chemical synthesis method of ribavirin condensate, the concrete steps of this method are as follows:

S1:将1-三甲基硅烷基-1H-1,2,4-三唑-3-甲酰胺12g、六甲基二硅胺300ml和硫酸铵1g添加至500ml的三颈瓶中,加热回流反应至澄清,加热的温度为100℃,加热时间为7h,冷却至室温;S1: Add 12g of 1-trimethylsilyl-1H-1,2,4-triazole-3-carboxamide, 300ml of hexamethyldisilamine and 1g of ammonium sulfate to a 500ml three-necked flask, heat to reflux React until clarification, the heating temperature is 100°C, the heating time is 7h, and cooled to room temperature;

S2:减压蒸干,得到黄色油状物,并将其溶于300ml的二氯甲烷中,在冰浴中添加四乙酰核糖40g,且冰浴的温度控制在5℃,随后滴加氯化锡7ml;S2: Evaporate to dryness under reduced pressure to obtain a yellow oil, and dissolve it in 300ml of dichloromethane, add 40g of tetraacetylribose in an ice bath, and control the temperature of the ice bath at 5°C, then add tin chloride dropwise 7ml;

S3:采用薄板层析色谱检测反应完全后,将反应液倒入碳酸氢钠的冰水中,剧烈搅拌后静置分层,有机相用饱和碳酸氢钠水溶液120ml,洗涤5次,无水硫酸钠干燥,过滤,滤液减压蒸去溶剂;S3: After the completion of the reaction is detected by thin-plate chromatography, the reaction solution is poured into ice water of sodium bicarbonate, stirred vigorously and left to stand for stratification, and the organic phase is washed 5 times with 120 ml of saturated aqueous sodium bicarbonate solution, anhydrous sodium sulfate Dry, filter, and evaporate the filtrate to remove the solvent under reduced pressure;

S4:将步骤S3制得的产物溶于甲醇的氨饱和溶液中,在室温下搅拌7h,析出白色沉淀,过滤,滤饼用甲醇洗涤后减压干燥;S4: dissolving the product obtained in step S3 in a saturated ammonia solution of methanol, stirring at room temperature for 7 hours, a white precipitate precipitated, filtered, and the filter cake was washed with methanol and dried under reduced pressure;

S5:随后添加乙醇,充分搅拌后过滤,滤饼用甲醇洗涤后,减压干燥并合并滤饼;S5: Add ethanol subsequently, filter after fully stirring, wash the filter cake with methanol, dry under reduced pressure and combine the filter cake;

S6:合并后的滤饼在加热条件下溶于95%、180ml的乙醇中,加热的温度为60℃,经过脱色剂脱色后,过滤冷却结晶,制得白色晶体粉末。S6: The combined filter cake is dissolved in 95% and 180ml of ethanol under heating conditions, the heating temperature is 60°C, after being decolorized by a decolorizing agent, it is filtered and cooled to crystallize to obtain a white crystal powder.

实施例三Embodiment three

一种利巴韦林缩合物的化学合成方法,该方法的具体步骤如下:A kind of chemical synthesis method of ribavirin condensate, the concrete steps of this method are as follows:

S1:将1-三甲基硅烷基-1H-1,2,4-三唑-3-甲酰胺11.5g、六甲基二硅胺260ml和硫酸铵0.8g添加至500ml的三颈瓶中,加热回流反应至澄清,加热的温度为97℃,加热时间为6h,冷却至室温;S1: Add 11.5g of 1-trimethylsilyl-1H-1,2,4-triazole-3-carboxamide, 260ml of hexamethyldisilamine and 0.8g of ammonium sulfate into a 500ml three-necked bottle, Heating to reflux reaction until clarification, the heating temperature is 97°C, the heating time is 6h, and cooled to room temperature;

S2:减压蒸干,得到黄色油状物,并将其溶于260ml的二氯甲烷中,在冰浴中添加四乙酰核糖35g,且冰浴的温度控制在2℃,随后滴加氯化锡6ml;S2: Evaporate to dryness under reduced pressure to obtain a yellow oil, and dissolve it in 260ml of dichloromethane, add 35g of tetraacetyl ribose in an ice bath, and control the temperature of the ice bath at 2°C, then add tin chloride dropwise 6ml;

S3:采用薄板层析色谱检测反应完全后,将反应液倒入碳酸氢钠的冰水中,剧烈搅拌后静置分层,有机相用饱和碳酸氢钠水溶液110ml,洗涤4次,无水硫酸钠干燥,过滤,滤液减压蒸去溶剂;S3: After the completion of the reaction is detected by thin-plate chromatography, the reaction solution is poured into ice water of sodium bicarbonate, stirred vigorously and left to stand for stratification, and the organic phase is washed 4 times with 110ml of saturated aqueous sodium bicarbonate solution, anhydrous sodium sulfate Dry, filter, and evaporate the filtrate to remove the solvent under reduced pressure;

S4:将步骤S3制得的产物溶于甲醇的氨饱和溶液中,在室温下搅拌6h,析出白色沉淀,过滤,滤饼用甲醇洗涤后减压干燥;S4: dissolving the product obtained in step S3 in a saturated ammonia solution of methanol, stirring at room temperature for 6 hours, a white precipitate precipitated, filtered, and the filter cake was washed with methanol and dried under reduced pressure;

S5:随后添加乙醇,充分搅拌后过滤,滤饼用甲醇洗涤后,减压干燥并合并滤饼;S5: Add ethanol subsequently, filter after fully stirring, wash the filter cake with methanol, dry under reduced pressure and combine the filter cake;

S6:合并后的滤饼在加热条件下溶于95%、160ml的乙醇中,加热的温度为50℃,经过脱色剂脱色后,过滤冷却结晶,制得白色晶体粉末。S6: The combined filter cake was dissolved in 95%, 160ml of ethanol under heating conditions, the heating temperature was 50°C, after being decolorized by a decolorizing agent, filtered and cooled to crystallize to obtain a white crystal powder.

酸度检测acidity test

取本品1.0g,加水50ml溶解后,加饱和氯化钾溶液0.2ml,摇匀,依法测定(2010年版药典二部附录ⅥH),pH值为4.0~6.5;Take 1.0g of this product, add 50ml of water to dissolve, add 0.2ml of saturated potassium chloride solution, shake well, and measure according to the law (2010 edition of Pharmacopoeia II Appendix VIH), the pH value is 4.0-6.5;

溶液的澄清度与颜色Clarity and color of the solution

取本品0.5g,加水10ml溶解后,溶液应澄清无色;Take 0.5g of this product, add 10ml of water to dissolve, the solution should be clear and colorless;

有关物质relative substance

取本品,加流动相溶解并制成每1ml中约含0.4mg的溶液作为供试品溶液,精密量取1ml,置100ml量瓶中,用流动相稀释至刻度,摇匀,作为对照溶液。照含量测定项下的色谱条件,取对照溶液20μl,注入液相色谱仪,调节仪器灵敏度,使主成分峰的峰高约为满量程的25%;再精密量取供试品溶液与对照溶液各20μl,分别注入液相色谱仪,记录色谱图至主成分峰保留时间的2倍,供试品溶液的色谱图中如有杂质峰,单个杂质的峰面积不得大于对照溶液主峰面积的0.25倍(0.25%),各杂质峰面积的和不得大于对照溶液的主峰面积(1.0%);Take this product, add mobile phase to dissolve and make a solution containing about 0.4mg per 1ml as the test solution, accurately measure 1ml, put it in a 100ml measuring bottle, dilute to the mark with mobile phase, shake well, and use it as a control solution . According to the chromatographic conditions under the content determination item, get contrast solution 20 μ l, inject liquid chromatograph, adjust instrument sensitivity, make the peak height of main component peak be about 25% of full scale; Then accurately measure need testing solution and contrast solution Each 20 μl was injected into the liquid chromatograph, and the chromatogram was recorded to twice the retention time of the main component peak. If there is an impurity peak in the chromatogram of the test solution, the peak area of a single impurity should not be greater than 0.25 times the main peak area of the control solution. (0.25%), the sum of each impurity peak area must not be greater than the main peak area (1.0%) of the contrast solution;

干燥失重Loss on drying

取本品,在105℃干燥至恒重,减失重量不得过0.5%(2010年版药典二部附录ⅧL);Take this product and dry it at 105°C to constant weight, and the weight loss should not exceed 0.5% (Appendix VIII L of Part Two of the Pharmacopoeia of the 2010 Edition);

炽灼残渣Residue on ignition

取本品1.0g,依法检查(2010年版药典二部附录ⅧN),遗留残渣不得过0.1%;Take 1.0g of this product, check according to law (Appendix VIII N of Part Two of the Pharmacopoeia, 2010 Edition), and the remaining residue shall not exceed 0.1%;

重金属heavy metal

取炽灼残渣项下遗留的残渣,依法检查(2010年版药典二部附录ⅧH第二法),含重金属不得过百万分之十;Take the residue left under the item of residue on ignition, and check it according to the law (2010 edition of Pharmacopoeia, Appendix ⅧH, second method), and the heavy metal content should not exceed 10 parts per million;

含量测定Assay

照高效液相色谱法(2010年版药典二部附录ⅤD)测定;Measure according to high performance liquid chromatography (2010 edition pharmacopoeia two appendix ⅤD);

色谱条件与系统适用性试验Chromatographic conditions and system suitability test

用磺化交联的苯乙烯一二乙烯基共聚物的氢型阳离子交换树脂为填充剂;以水(用稀硫酸调节pH值至2.5±0.1)为流动相;检测波长为207nm。理论板数按利巴韦林峰计算不低于2000;Use sulfonated cross-linked styrene-divinyl copolymer hydrogen type cation exchange resin as filler; use water (adjust pH value to 2.5±0.1 with dilute sulfuric acid) as mobile phase; detection wavelength is 207nm. The number of theoretical plates is not less than 2000 based on ribavirin peak calculation;

测定法Assay

取本品,精密称定,加流动相溶解并定量稀释制成每1ml中约含利巴韦林50μg的溶液,精密量取20μl注入液相色谱仪,记录色谱图;另取利巴韦林对照品适量,同法测定。按外标法以峰面积计算,即得;Take this product, accurately weigh it, add mobile phase to dissolve and quantitatively dilute to make a solution containing about 50 μg of ribavirin per 1 ml, accurately measure 20 μl and inject it into the liquid chromatograph, and record the chromatogram; take another ribavirin An appropriate amount of reference substance was determined in the same way. According to the external standard method to calculate the peak area, that is;

贮藏storage

遮光,密封保存。Shade, sealed and stored.

综合以上所述,本发明的最佳实施例为实施例三,本发明改进后的工艺原料易得,反应条件温和,各中间体均无需分离纯化,操作简便,总收率能够达到65%以上,制得的利巴韦林的纯度为99%以上。尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。Based on the above, the best embodiment of the present invention is Embodiment 3. The improved process raw materials of the present invention are easy to obtain, the reaction conditions are mild, the intermediates do not need to be separated and purified, the operation is simple, and the total yield can reach more than 65%. , the purity of the prepared ribavirin is more than 99%. Although the embodiments of the present invention have been shown and described, those skilled in the art can understand that various changes, modifications and substitutions can be made to these embodiments without departing from the principle and spirit of the present invention. and modifications, the scope of the invention is defined by the appended claims and their equivalents.

Claims (8)

1. a kind of chemical synthesis process of ribavirin condensation compound, it is characterised in that:This method is as follows:
S1:By 1- trimethylsilyls -1H-1,2,4- triazole -3- formamides, hmds and ammonium sulfate are added to In the three-necked bottle of 500ml, heating reflux reaction is cooled to room temperature to clarifying;
S2:Evaporated under reduced pressure obtains yellow oil, and is dissolved in the dichloromethane of 200~300ml, adds four acetyl cores Stannic chloride is then added dropwise in sugar;
S3:After the reaction was complete, reaction solution is poured into the ice water of sodium bicarbonate, after being vigorously stirred using the detection of thin plate chromatography chromatography Stratification, organic phase are washed with saturated sodium bicarbonate aqueous solution, anhydrous sodium sulfate drying, filtering, and filtrate decompression boils off solvent;
S4:Product made from step S3 is dissolved in the ammonia saturated solution of methanol, 5~7h is stirred at room temperature, it is heavy that white is precipitated It forms sediment, filtering, filter cake is dried under reduced pressure after being washed with methanol;
S5:Then addition ethyl alcohol, filters after being sufficiently stirred, after filter cake is washed with methanol, is dried under reduced pressure and merges filter cake;
S6:Filter cake after merging is dissolved in ethyl alcohol in a heated condition, after bleaching agent bleaching, is filtered crystallisation by cooling, is made White crystalline powder.
2. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step In S1, the additive amount of 1- trimethylsilyls -1H-1,2,4- triazole -3- formamides are 11~12g, and hmds adds Dosage is 200~300ml, and the additive amount of ammonium sulfate is 0.5~1g.
3. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step In S1, the temperature of heating is 95~100 DEG C, and heating time is 5~7h.
4. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step In S2, the additive amount of 1,2,3,5-Tetra-O-Acetyl-D-Ribose is 30~40g, and the dripping quantity of stannic chloride is 5~7ml.
5. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step It in S2, when adding 1,2,3,5-Tetra-O-Acetyl-D-Ribose, is carried out in ice bath, and the temperature of ice bath is controlled at 0~5 DEG C.
6. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step In S3, sodium bicarbonate aqueous solution is 100~120ml, is washed 3~5 times.
7. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step In S6, the temperature of heating is 40~60 DEG C, and is dissolved in the ethanol solution of 95%, 150~180ml.
8. a kind of chemical synthesis process of ribavirin condensation compound according to claim 1, it is characterised in that:The step In S6, decolorising agent is one kind in activated carbon, carclazyte or absorption resin.
CN201810687926.0A 2018-06-28 2018-06-28 A kind of chemical synthesis process of ribavirin condensation compound Pending CN108484691A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810687926.0A CN108484691A (en) 2018-06-28 2018-06-28 A kind of chemical synthesis process of ribavirin condensation compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810687926.0A CN108484691A (en) 2018-06-28 2018-06-28 A kind of chemical synthesis process of ribavirin condensation compound

Publications (1)

Publication Number Publication Date
CN108484691A true CN108484691A (en) 2018-09-04

Family

ID=63343493

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810687926.0A Pending CN108484691A (en) 2018-06-28 2018-06-28 A kind of chemical synthesis process of ribavirin condensation compound

Country Status (1)

Country Link
CN (1) CN108484691A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1535277A (en) * 2001-07-30 2004-10-06 �����ﰲ�ط���������ѧ(�����)�ɷ��� Process for preparation of L-ribavirin
CN101397316A (en) * 2008-10-23 2009-04-01 浙江工业大学 Chemical synthesis method of ribavirin condensation compound
WO2017155923A1 (en) * 2016-03-07 2017-09-14 Emory University Nucleotide and nucleoside therapeutic compositions and uses related thereto

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1535277A (en) * 2001-07-30 2004-10-06 �����ﰲ�ط���������ѧ(�����)�ɷ��� Process for preparation of L-ribavirin
CN101397316A (en) * 2008-10-23 2009-04-01 浙江工业大学 Chemical synthesis method of ribavirin condensation compound
WO2017155923A1 (en) * 2016-03-07 2017-09-14 Emory University Nucleotide and nucleoside therapeutic compositions and uses related thereto

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
蔡玉瑛等: "利巴韦林的合成", 《中国医药工业杂志》 *

Similar Documents

Publication Publication Date Title
KR102416279B1 (en) Pyrazole compounds as modulators of fshr and uses thereof
RU2663898C2 (en) Pyrazole compounds as modulators of fshr and uses thereof
WO2013134415A1 (en) Mannose derivatives for treating bacterial infections
CN104610166B (en) Pyrimidine benzyl hydroxamic acid histone deacetylases inhibitor and preparation method and application
CN102558061B (en) Synthetic method of ozagrel
CN102180833B (en) Preparation method and detection method of edaravone dimer and tautomer thereof
US10683265B1 (en) Cannabidiol-3-sulfonic acid, preparation method and application thereof, and cannabidiol derivative
CN104045669B (en) A kind of separation method of the chemosynthesis rhodioside of applicable industrialized production
CN105503845A (en) Defluorinated canagliflozin compound, and preparation method and application thereof
CN102086196B (en) Novel method for refining aztreonam
CN103772449B (en) C aryl glucoside derivatives and preparation method thereof and purposes
JP6673932B2 (en) Indole and azaindole derivatives and their use in neurodegenerative diseases
CN113004244A (en) Trelagliptin impurity and preparation method and application thereof
CN108017619B (en) Topiroxostat impurity and preparation method thereof
CN108484691A (en) A kind of chemical synthesis process of ribavirin condensation compound
CN108218928A (en) Bicyclic derivatives of glucoside and its preparation method and application
CN108264500B (en) Substituted 2-aminopyridines and preparation method thereof
CN109096270A (en) A kind of canagliflozin 4- position isomer impurity and preparation method thereof
CN111793017A (en) Preparation method of lactam compound
JP2019518052A (en) Dihydropyrazoloazepine compounds as Akt inhibitors
CN106349145A (en) Method for preparing intelligence-improving medicine (S)-oxiracetam
JP2016539186A (en) Taxane compounds, methods for their preparation and uses thereof
NL8700731A (en) PROCESS FOR THE PREPARATION OF MORANOLINE DERIVATIVES.
CN104163769A (en) Preparation method of propionyl levocarnitine hydrochloride
CN115925650B (en) Epalrestat eutectic and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180904

RJ01 Rejection of invention patent application after publication